 
                        | Product NDC: | 0832-0233 | 
| Proprietary Name: | Morphine Sulfate | 
| Non Proprietary Name: | Morphine Sulfate | 
| Active Ingredient(s): | 100 mg/1 & nbsp; Morphine Sulfate | 
| Administration Route(s): | ORAL | 
| Dosage Form(s): | CAPSULE, EXTENDED RELEASE | 
| Coding System: | National Drug Codes(NDC) | 
| Product NDC: | 0832-0233 | 
| Labeler Name: | Upsher-Smith Laboratories, Inc. | 
| Product Type: | HUMAN PRESCRIPTION DRUG | 
| FDA Application Number: | ANDA202104 | 
| Marketing Category: | ANDA | 
| Start Marketing Date: | 20130630 | 
| Package NDC: | 0832-0233-00 | 
| Package Description: | 100 CAPSULE, EXTENDED RELEASE in 1 BOTTLE (0832-0233-00) | 
| NDC Code | 0832-0233-00 | 
| Proprietary Name | Morphine Sulfate | 
| Package Description | 100 CAPSULE, EXTENDED RELEASE in 1 BOTTLE (0832-0233-00) | 
| Product NDC | 0832-0233 | 
| Product Type Name | HUMAN PRESCRIPTION DRUG | 
| Non Proprietary Name | Morphine Sulfate | 
| Dosage Form Name | CAPSULE, EXTENDED RELEASE | 
| Route Name | ORAL | 
| Start Marketing Date | 20130630 | 
| Marketing Category Name | ANDA | 
| Labeler Name | Upsher-Smith Laboratories, Inc. | 
| Substance Name | MORPHINE SULFATE | 
| Strength Number | 100 | 
| Strength Unit | mg/1 | 
| Pharmaceutical Classes | Full Opioid Agonists [MoA],Opioid Agonist [EPC] |